Clinical Trial Versus Real-World Outcomes With Anti-VEGF Therapy for Central Retinal Vein Occlusion

被引：0
|
作者：
Bhisitkul, Robert B. [1 ]
Blotner, Steven [2 ]
Steffen, Verena [2 ]
Haskova, Zdenka [2 ]
机构：
[1] Univ Calif San Francisco, Ophthalmol, San Francisco, CA 94143 USA
[2] Genentech Inc, San Francisco, CA 94080 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2020年 / 61卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1304
引用
收藏
页数：3
相关论文
共 50 条
  • [11] Retinal vein occlusion: Anti-VEGF treatments
    Nghiem-Buffet, S.
    Cohen, S. -Y.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2009, 32 (09): : 679 - 686
  • [12] Visual acuity outcomes and anti-VEGF therapy intensity in macular oedema due to retinal vein occlusion: a real-world analysis of 15 613 patient eyes
    Ciulla, Thomas
    Pollack, John S.
    Williams, David F.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2021, 105 (12) : 1696 - 1704
  • [13] Real-world outcomes in patients with macular oedema secondary to branch retinal vein occlusion receiving intravitreal anti-VEGF therapy in a UK public hospital setting
    Ang, Juan L.
    Ah-Moye, Sarah
    Zalmay, Pardis
    Vuong Nguyen
    Gillies, Mark
    Mehta, Hemal
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 47 : 154 - 154
  • [14] RANIBIZUMAB IN PREPROLIFERATIVE (ISCHEMIC) CENTRAL RETINAL VEIN OCCLUSION The Rubeosis Anti-VEGF (RAVE) Trial
    Brown, David M.
    Wykoff, Charles C.
    Wong, Tien P.
    Mariani, Angeline F.
    Croft, Daniel E.
    Schuetzle, Karri L.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2014, 34 (09): : 1728 - 1735
  • [15] Epidemiologic Data and Visual Outcomes in Patients with Central Retinal Vein Occlusion in the Anti-VEGF Era
    Constantine, Ryan
    Thomas, Akshay
    Berry, Duncan
    Stinnett, Sandra S.
    Fekrat, Sharon
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [16] Anti-VEGF therapy in the treatment of anterior segment neovascularization secondary to central retinal vein occlusion
    Kabesha, T. B.
    Glacet-Bernard, A.
    Rostaqui, O.
    Souied, E. H.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2015, 38 (05): : 414 - 420
  • [17] Central Retinal Vein Occlusion 36-Month Outcomes with Anti-VEGF The Fight Retinal Blindness! Registry
    Hunt, Adrian
    Nguyen, Vuong
    Bhandari, Sanjeeb
    Ponsioen, Theodorus
    McAllister, Ian L.
    Arnold, Jennifer
    Young, Stephanie
    Gabrielle, Pierre-Henry
    Mehta, Hemal
    O Toole, Louise
    Alforja, Socorro
    Zarranz-Ventura, Javier
    Barthelmes, Daniel
    Gillies, Mark
    OPHTHALMOLOGY RETINA, 2023, 7 (04): : 338 - 345
  • [18] Foveal Thickness Fluctuations in Anti-VEGF Treatment for Central Retinal Vein Occlusion
    Nagasato, Daisuke
    Muraoka, Yuki
    Tanabe, Mao
    Nishigori, Naomi
    Osaka, Rie
    Mitamura, Yoshinori
    Tabuchi, Hitoshi
    Murakami, Tomoaki
    Ooto, Sotaro
    Suzuma, Kiyoshi
    Tsujikawa, Akitaka
    OPHTHALMOLOGY SCIENCE, 2024, 4 (02):
  • [19] Parafoveal retinal sensitivity in branch retinal vein occlusion after anti-VEGF therapy
    Tomita, Ryutaro
    Ojima, Akira
    Kato, Yutaka
    Sekiryu, Tetsuju
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [20] Comparison of real-world outcomes in patients with branch retinal vein occlusion (BRVO) related macular edema (ME) treated with anti-VEGF injections alone or anti-VEGF injections combined with focal laser
    Gross, Cole
    Thomley, Meredith
    Crosson, Jason
    Preda-Naumescu, Ana
    Chen, Kelly
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
12345